You are here

Home > News > All Press Releases

Press Releases

Ada Yonath, photographed for the L’Oréal-UNESCO Award for Women in Science, 2008. Credit: Micheline Pelletier/Corbis

Prof. Ada Yonath, Nobel Laureate and a Model of Scientific Perseverance, Has Passed Away

31.08.2026
Chemistry, Organic Chemistry, Structural Biology, Benefiting Humanity
From pursuing an impossible dream to uncovering one of the cell’s best-kept secrets and advancing the design of improved antibiotics
Credit: XENON Collaboration/Luigi Di Carlo

A New Window on the Universe: Solar Neutrinos Measured at Record-Low Energies

31.08.2026
Astrophysics, Nano Physics, Particle Physics
XENONnT offers an unprecedented glimpse into one of nature’s rarest interactions. Project member Prof. Ranny Budnik of the Weizmann Institute of Science: “We have entered an era in which we can see things that were previously beyond our reach”
Intestinal organoids grown in the lab from stem cells derived from patients. Each sphere represents one organoid. Photo: Petro Busko, a PhD student in Biton’s lab

When the Gut Can’t Forget: A New Mechanism Promoting Inflammatory Bowel Disease

26.08.2026
Stem Cells, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics
Weizmann Institute researchers discover that transient intestinal inflammation can leave irreversible changes in the gut lining, leading to Crohn’s disease and ulcerative colitis. The findings point to new directions for treatment and early detection
Shutterstock

Viagra May Reduce Cancer Metastasis, Study Shows

21.07.2026
Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics
The blockbuster drug may strengthen a newly discovered cholesterol-regulating mechanism that could be harnessed to curb cancer spread
Shutterstock

Immune Therapy for Alzheimer's Takes a Step Forward

15.07.2026
Brain & Behavior, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs
Phase 1 trial reports positive results for a brain-protective immunotherapy in early Alzheimer's disease.
One Plant, Three Kingdoms, Five Trips

One Plant, Three Kingdoms, Five Trips

24.06.2026
Brain & Behavior, Disease, Drugs & Diagnostics, Plants and Agriculture, Biotechnology
Weizmann Institute scientists decipher how a well-known psychedelic substance is created, then engineer a plant to produce several psychedelics at once
Weizmann School of Science presents: the class of 2026

“Be Scientists and Be Human Beings”

16.06.2026
Benefiting Humanity
Weizmann Institute of Science celebrates 124 new PhD graduates – more than 20 percent of them international students – and 227 master’s degree recipients. Meet the class of 2026
Credit: NASA/JPL-Caltech/SETI Institute

Before the Aliens, the Amino Acids

10.06.2026
Astrophysics, Planetary Science, Organic Chemistry
A Weizmann-led team proposes a simple but powerful new method for detecting traces of alien biology, whether on Jupiter’s icy moons, in meteorites or in Martian samples
Shutterstock

Pandemic in Fast Forward

02.06.2026
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Evolution and Development
Israeli and Czech scientists recreated the coronavirus’s evolutionary journey in a test tube – revealing the conditions that can produce highly contagious variants
Scavenger cells (green) engulf activated B cells (pink), thereby suppressing local immune response. The cells were imaged in three dimensions using a confocal microscope

When the Body Remembers the Tumor

26.05.2026
Cancer, Immunology, Disease, Drugs & Diagnostics
Weizmann Institute researchers discover immune memory cells capable of producing antibodies against cancer – a finding that opens new avenues for future cancer vaccines

Pages

 

Are you a journalist? Please sign up here for our press releases

 

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research